| [1] |
Westra WH, Lewis JS Jr. Update from the 4th edition of the World Health Organization Classification of Head and Neck Tumours: Oropharynx[J]. Head Neck Pathol, 2017,11(1):41-47. DOI: 10.1007/s12105-017-0793-2.
doi: 10.1007/s12105-017-0793-2
pmid: 28247229
|
| [2] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424. DOI: 10.3322/caac.21492.
doi: 10.3322/caac.21492
pmid: 30207593
|
| [3] |
Farazi TA, Hoell JI, Morozov P, et al. microRNAs in human cancer[J]. Adv Exp Med Biol, 2013,774(2):1-20. DOI: 10.1007/978-94-007-5590-1_17.
|
| [4] |
Zhu X, Li W, Zhang R, et al. MicroRNA-342 inhibits cell proliferation and invasion in nasopharyngeal carcinoma by directly targeting ZEB1[J]. Oncol Lett, 2018,16:1298-1304. DOI: 10.3892/ol.2018.8788.
doi: 10.3892/ol.2018.8788
pmid: 30061949
|
| [5] |
Cheng JZ, Chen JJ, Wang ZG, et al. MicroRNA-185 inhibits cell proliferation while promoting apoptosis and autophagy through negative regulation of TGF-beta1/mTOR axis and HOXC6 in nasopharyngeal carcinoma[J]. Cancer Biomark, 2018,23(1):107-123. DOI: 10.3233/CBM-181459.
doi: 10.3233/CBM-181459
pmid: 29991129
|
| [6] |
Zhang Y, Xu Z. MiR-93 enhances cell proliferation by directly targeting CDKN1A in nasopharyngeal carcinoma[J]. Oncol Lett, 2018,15(2):1723-1727. DOI: 10.3892/ol.2017.7492.
doi: 10.3892/ol.2017.7492
pmid: 29434867
|
| [7] |
Wu W, Chen X, Yu S, et al. MicroRNA-222 promotes tumor growth and confers radioresistance in nasopharyngeal carcinoma by targeting PTEN[J]. Mol Med Rep, 2018,17(1):1305-1310. DOI: 10.3892/mmr.2017.7931.
doi: 10.3892/mmr.2017.7931
pmid: 29115464
|
| [8] |
Huang P, Mao LF, Zhang ZP, et al. Down-regulated miR-125a-5p promotes the reprogramming of glucose metabolism and cell malignancy by increasing levels of CD147 in thyroid cancer[J]. Thyroid, 2018,28(5):613-623. DOI: 10.1089/thy.2017.0401.
doi: 10.1089/thy.2017.0401
pmid: 29634399
|
| [9] |
Natalia MA, Alejandro GT, Virginia TJ, et al. MARK1 is a novel target for miR-125a-5p: implications for cell migration in cervical tumor cells[J]. Microrna, 2018,7(1):54-61. DOI: 10.2174/2211536606666171024160244.
doi: 10.2174/2211536606666171024160244
pmid: 29076440
|
| [10] |
付西峰, 董秀山, 高飞, 等. 成纤维生长因子2在胰腺癌中的表达及对胰腺癌细胞侵袭与转移的作用和机制[J]. 山西医科大学学报, 2017,48(5):26-31. DOI: 10.13753/j.issn.1007-6611.2017.05.005.
|
| [11] |
Hou L, Pei L, Ma Y, et al. MicroRNA-125a-3p downregulation correlates with tumorigenesis and poor prognosis in patients with non-small cell lung cancer[J]. Oncol Lett, 2017,14(4):4441-4448. DOI: 10.3892/ol.2017.6809.
doi: 10.3892/ol.2017.6809
pmid: 29085440
|
| [12] |
Huang X, Zhang T, Li G, et al. Regulation of miR-125a expression by rs12976445 single-nucleotide polymorphism is associated with radiotherapy-induced pneumonitis in lung carcinoma patients[J]. J Cell Biochem, 2019,120(3):4485. DOI: 10.1002/jcb.27736.
doi: 10.1002/jcb.27736
pmid: 30302847
|
| [13] |
Jin L, Zhang Z, Li Y, et al. MiR-125b is associated with renal cell carcinoma cell migration, invasion and apoptosis[J]. Oncol Lett, 2017,13(6):4512-4520. DOI: 10.3892/ol.2017.5985.
doi: 10.3892/ol.2017.5985
pmid: 28599452
|
| [14] |
Zhao A, Zeng Q, Xie X, et al. MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression[J]. J Genet Genomics, 2012,39(1):29-35. DOI: 10.1016/j.jgg.2011.12.003.
doi: 10.1016/j.jgg.2011.12.003
|
| [15] |
Zhang L, Yu H, Badzio A, et al. Fibroblast growth factor receptor 1 and related ligands in small-cell lung cancer[J]. J Thorac Oncol, 2015,10(7):1083-1090. DOI: 10.1097/JTO.000000000000-0562.
doi: 10.1097/JTO.0000000000000562
pmid: 26020126
|
| [16] |
Sharpe R, Pearson A, Herrera-Abreu MT, et al. FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo[J]. Clin Cancer Res, 2011,17(16):5275-5286. DOI: 10.1158/0008-5472.SABCS10-P5-02-01.
doi: 10.1158/1078-0432.CCR-10-2727
pmid: 21712446
|